Alexandria Hammond

Stock Analyst at B of A Securities

(0.35)
# 2759
Out of 5,441 analysts
16
Total ratings
Success rate
Average return
13 Stocks
Name Action PT Current % Upside Ratings Updated
AKRO Akero Therapeutics
Maintains: Strong Buy
63 64
48.32 32.45% 4 May 27, 2025
REGN Regeneron Pharmaceut...
Initiates Coverage On: Outperform
1150
546.18 110.55% 1 Nov 15, 2024
PFE Pfizer
Initiates Coverage On: Underperform
25
24.61 1.58% 1 Nov 15, 2024
MRNA Moderna
Initiates Coverage On: Underperform
40
25.48 56.99% 1 Nov 15, 2024
MRK Merck & Co
Initiates Coverage On: Peer Perform
n/a
n/a n/a 1 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
1000
635.48 57.36% 1 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
190
173.87 9.28% 1 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
110
120.57 -8.77% 1 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Peer Perform
n/a
n/a n/a 1 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Peer Perform
n/a
n/a n/a 1 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
205
198.62 3.21% 1 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Underperform
150
349.43 -57.07% 1 Apr 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
30
8.76 242.47% 1 Apr 22, 2024